{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:01:10Z","timestamp":1762783270678,"version":"3.41.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003285"],"award-info":[{"award-number":["82003285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14382-8","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T10:53:00Z","timestamp":1749034380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification and validation of a DNA methylation-block prognostic model in non-small cell lung cancer patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Hang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangqiu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"14382_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"14382_CR2","first-page":"22","volume":"39","author":"R-M Feng","year":"2019","unstructured":"Feng R-M, Zong Y-N, Cao S-M, Xu R-H. Current cancer situation in China: good or bad news from the 2018 global Cancer statistics?? Cancer Commun (Lond). 2019;39:22.","journal-title":"Cancer Commun (Lond)"},{"key":"14382_CR3","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s40265-022-01721-3","volume":"82","author":"J Isaacs","year":"2022","unstructured":"Isaacs J, Stinchcombe TE. Neoadjuvant and adjuvant systemic therapy for Early-Stage Non-small-Cell lung Cancer. Drugs. 2022;82:855\u201363.","journal-title":"Drugs"},{"key":"14382_CR4","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1158\/1078-0432.CCR-04-2661","volume":"11","author":"S Singhal","year":"2005","unstructured":"Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR, Albelda SM. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res. 2005;11:3974\u201386.","journal-title":"Clin Cancer Res"},{"key":"14382_CR5","doi-asserted-by":"publisher","first-page":"621435","DOI":"10.3389\/fonc.2020.621435","volume":"10","author":"H Li","year":"2020","unstructured":"Li H, Li B, Pan Y, Zhang Y, Xiang J, Zhang Y, et al. Preoperative folate Receptor-Positive Circulating tumor cell level is a prognostic factor of long term outcome in Non-Small cell lung Cancer patients. Front Oncol. 2020;10:621435.","journal-title":"Front Oncol"},{"key":"14382_CR6","doi-asserted-by":"publisher","first-page":"a019505","DOI":"10.1101\/cshperspect.a019505","volume":"8","author":"SB Baylin","year":"2016","unstructured":"Baylin SB, Jones PA. Epigenetic determinants of Cancer. Cold Spring Harb Perspect Biol. 2016;8:a019505.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"14382_CR7","doi-asserted-by":"publisher","first-page":"8107318","DOI":"10.1155\/2019\/8107318","volume":"2019","author":"Y-X Shi","year":"2019","unstructured":"Shi Y-X, Sheng D-Q, Cheng L, Song X-Y. Current landscape of epigenetics in lung cancer: focus on the mechanism and application. J Oncol. 2019;2019:8107318.","journal-title":"J Oncol"},{"key":"14382_CR8","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.ejca.2005.02.020","volume":"41","author":"R Dammann","year":"2005","unstructured":"Dammann R, Strunnikova M, Schagdarsurengin U, Rastetter M, Papritz M, Hattenhorst UE, et al. CpG Island methylation and expression of tumour-associated genes in lung carcinoma. Eur J Cancer. 2005;41:1223\u201336.","journal-title":"Eur J Cancer"},{"key":"14382_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/epi.09.33","volume":"1","author":"M Ehrlich","year":"2009","unstructured":"Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics. 2009;1:239\u201359.","journal-title":"Epigenomics"},{"key":"14382_CR10","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3390\/ijms19041166","volume":"19","author":"GP Pfeifer","year":"2018","unstructured":"Pfeifer GP. Defining driver DNA methylation changes in human Cancer. Int J Mol Sci. 2018;19:1166.","journal-title":"Int J Mol Sci"},{"key":"14382_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1476-4598-7-81","volume":"7","author":"PP Anglim","year":"2008","unstructured":"Anglim PP, Alonzo TA, Laird-Offringa IA. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol Cancer. 2008;7:81.","journal-title":"Mol Cancer"},{"key":"14382_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.semcancer.2017.09.005","volume":"51","author":"M Duruisseaux","year":"2018","unstructured":"Duruisseaux M, Esteller M. Lung cancer epigenetics: from knowledge to applications. Semin Cancer Biol. 2018;51:116\u201328.","journal-title":"Semin Cancer Biol"},{"key":"14382_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21037\/tlcr.2019.12.08","volume":"8","author":"M \u0160uti\u0107","year":"2019","unstructured":"\u0160uti\u0107 M, Motzek A, Bubanovi\u0107 G, Linke M, Sabol I, Vugrek O, et al. Promoter methylation status of ASC\/TMS1\/PYCARD is associated with decreased overall survival and TNM status in patients with early stage non-small cell lung cancer (NSCLC). Transl Lung Cancer Res. 2019;8:1000\u201315.","journal-title":"Transl Lung Cancer Res"},{"key":"14382_CR14","doi-asserted-by":"publisher","first-page":"8377","DOI":"10.1002\/cam4.4339","volume":"10","author":"H Li","year":"2021","unstructured":"Li H, Ma Z-L, Li B, Pan Y-J, Xiang J-Q, Zhang Y-W, et al. Potential utility of longitudinal somatic mutation and methylation profiling for predicting molecular residual disease in postoperative non-small cell lung cancer patients. Cancer Med. 2021;10:8377\u201386.","journal-title":"Cancer Med"},{"key":"14382_CR15","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jtho.2023.02.019","volume":"18","author":"J Zhao","year":"2023","unstructured":"Zhao J, Zhao L, Guo W, Wang S, Tao X, Li L, et al. Efficacy, safety, and biomarker analysis of neoadjuvant camrelizumab and apatinib in patients with resectable NSCLC: A phase 2 clinical trial. J Thorac Oncol. 2023;18:780\u201391.","journal-title":"J Thorac Oncol"},{"key":"14382_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s12276-020-00493-8","volume":"52","author":"J-W Cho","year":"2020","unstructured":"Cho J-W, Hong MH, Ha S-J, Kim Y-J, Cho BC, Lee I, et al. Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer. Exp Mol Med. 2020;52:1550\u201363.","journal-title":"Exp Mol Med"},{"key":"14382_CR17","doi-asserted-by":"publisher","first-page":"959868","DOI":"10.3389\/fimmu.2023.959868","volume":"14","author":"L Luo","year":"2023","unstructured":"Luo L, Fu S, Du W, He L-N, Zhang X, Wang Y, et al. LRRC3B and its promoter hypomethylation status predicts response to anti-PD-1 based immunotherapy. Front Immunol. 2023;14:959868.","journal-title":"Front Immunol"},{"key":"14382_CR18","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMoa0706550","volume":"358","author":"MV Brock","year":"2008","unstructured":"Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 2008;358:1118\u201328.","journal-title":"N Engl J Med"},{"key":"14382_CR19","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/1878-0261.12848","volume":"15","author":"S Mastoraki","year":"2021","unstructured":"Mastoraki S, Balgkouranidou I, Tsaroucha E, Klinakis A, Georgoulias V, Lianidou E. KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer. Mol Oncol. 2021;15:2412\u201322.","journal-title":"Mol Oncol"},{"key":"14382_CR20","doi-asserted-by":"publisher","first-page":"14649","DOI":"10.18632\/aging.103517","volume":"12","author":"R Luo","year":"2020","unstructured":"Luo R, Song J, Xiao X, Xie Z, Zhao Z, Zhang W, et al. Identifying CpG methylation signature as a promising biomarker for recurrence and immunotherapy in non-small-cell lung carcinoma. Aging. 2020;12:14649\u201376.","journal-title":"Aging"},{"key":"14382_CR21","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrc1432","volume":"4","author":"SA Belinsky","year":"2004","unstructured":"Belinsky SA. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer. 2004;4:707\u201317.","journal-title":"Nat Rev Cancer"},{"key":"14382_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13041-021-00886-4","volume":"14","author":"Y Xu","year":"2021","unstructured":"Xu Y, Huang Z, Yu X, Chen K, Fan Y. Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases. Mol Brain. 2021;14:176.","journal-title":"Mol Brain"},{"key":"14382_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12916-021-02201-3","volume":"20","author":"B Luo","year":"2022","unstructured":"Luo B, Ma F, Liu H, Hu J, Rao L, Liu C, et al. Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma. BMC Med. 2022;20:8.","journal-title":"BMC Med"},{"key":"14382_CR24","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41551-021-00746-5","volume":"5","author":"N Liang","year":"2021","unstructured":"Liang N, Li B, Jia Z, Wang C, Wu P, Zheng T, et al. Ultrasensitive detection of Circulating tumour DNA via deep methylation sequencing aided by machine learning. Nat Biomed Eng. 2021;5:586\u201399.","journal-title":"Nat Biomed Eng"},{"key":"14382_CR25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jtho.2016.11.2235","volume":"12","author":"X Mao","year":"2017","unstructured":"Mao X, Zhang Z, Zheng X, Xie F, Duan F, Jiang L, et al. Capture-Based targeted ultradeep sequencing in paired tissue and plasma samples demonstrates differential subclonal ctDNA-Releasing capability in advanced lung Cancer. J Thorac Oncol. 2017;12:663\u201372.","journal-title":"J Thorac Oncol"},{"key":"14382_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet"},{"key":"14382_CR27","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gky1038","volume":"47","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47:D419\u201326.","journal-title":"Nucleic Acids Res"},{"key":"14382_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999;27:29\u201334.","journal-title":"Nucleic Acids Res"},{"key":"14382_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0006-291X(85)91424-X","volume":"129","author":"T Yamauchi","year":"1985","unstructured":"Yamauchi T, Fujisawa H. Self-regulation of calmodulin-dependent protein kinase II and glycogen synthase kinase by autophosphorylation. Biochem Biophys Res Commun. 1985;129:213\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"14382_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.21037\/atm.2019.03.28","volume":"7","author":"AE Revelo","year":"2019","unstructured":"Revelo AE, Martin A, Velasquez R, Kulandaisamy PC, Bustamante J, Keshishyan S, et al. Liquid biopsy for lung cancers: an update on recent developments. Ann Transl Med. 2019;7:349.","journal-title":"Ann Transl Med"},{"key":"14382_CR31","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/JTO.0b013e3182863ed2","volume":"8","author":"RH Carvalho","year":"2013","unstructured":"Carvalho RH, Hou J, Haberle V, Aerts J, Grosveld F, Lenhard B, et al. Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas. J Thorac Oncol. 2013;8:562\u201373.","journal-title":"J Thorac Oncol"},{"key":"14382_CR32","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1080\/15592294.2017.1311434","volume":"12","author":"G Liang","year":"2017","unstructured":"Liang G, Weisenberger DJ. DNA methylation aberrancies as a guide for surveillance and treatment of human cancers. Epigenetics. 2017;12:416\u201332.","journal-title":"Epigenetics"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14382-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14382-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T23:02:14Z","timestamp":1749078134000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14382-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14382"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14382-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval for this study was obtained from the ethics committee at Fudan University Shanghai Cancer Center (No: 2017-151-1354). Informed consent to participate was obtained from all of the participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"There were no identifying images or other personal or clinical details of participants that compromise their anonymity in this study. The consents for publication were also collected from all the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"999"}}